SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Elmer who wrote (6815)7/25/2002 8:00:01 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
I'd say it would be a negative on balance. They'd likely provide more money for a prescription benefit, but they'd certainly demand something from pharma in return in the way of lower prices.

Some of the pressure may come off prescription spending once Prilosec and Claritin are generic to add to all the recent generics of late.

Peter